“Sustained Complete Response to a Short Course of Subcutaneous Daratumumab in Multi-Refractory Immune Thrombocytopenia”. 2026. Mediterranean Journal of Hematology and Infectious Diseases 18 (1): e2026069. https://doi.org/10.4084/MJHID.2026.069.